138 related articles for article (PubMed ID: 35777066)
21. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
22. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
23. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.
Rosenbaum-Krumme SJ; Görges R; Bockisch A; Binse I
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1373-80. PubMed ID: 22718304
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K
Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523
[TBL] [Abstract][Full Text] [Related]
26. Pitfall of I-131 whole body scan: a mucinous adenocarcinoma of the ovary.
Sellem A; Msakni I; Elajmi W; Hammami H
Pan Afr Med J; 2020; 36():72. PubMed ID: 32774631
[TBL] [Abstract][Full Text] [Related]
27. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
Abhyankar A; Basu S
J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET performed concurrently with initial I-131 ablation for differentiated thyroid cancer.
Iwano S; Kato K; Ito S; Tsuchiya K; Naganawa S
Ann Nucl Med; 2012 Apr; 26(3):207-13. PubMed ID: 22160654
[TBL] [Abstract][Full Text] [Related]
29. NIS and epithelial-mesenchymal transition marker expression of circulating tumor cells for predicting and monitoring the radioactive iodine-131 therapy effect in differentiated thyroid cancers.
Zheng L; Wang G; Guo W; Pan D; Xie L; He S; Luo C; Li H; Ran Y; Wu S; Liu F; Zhang X; Huang D
Mol Biol Rep; 2019 Aug; 46(4):4201-4212. PubMed ID: 31147861
[TBL] [Abstract][Full Text] [Related]
30. An Unusual False-Positive Uptake of Radioiodine Caused by Posttraumatic Superficial Scab.
Xiao L; Jiang L; Huang R; Tian R; Liu B
Clin Nucl Med; 2022 Apr; 47(4):350-351. PubMed ID: 34739399
[TBL] [Abstract][Full Text] [Related]
31. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
32. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Schmidt M; Dietlein M; Schröder U; Schicha H
Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
[TBL] [Abstract][Full Text] [Related]
33. Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.
Lee SJ; Choi KC; Han JP; Park YE; Choi MG
J Endocrinol Invest; 2007 Jan; 30(1):28-34. PubMed ID: 17318019
[TBL] [Abstract][Full Text] [Related]
34. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.
Moon SH; Oh YL; Choi JY; Baek CH; Son YI; Jeong HS; Choe YS; Lee KH; Kim BT
Endocr Res; 2013; 38(2):77-84. PubMed ID: 22888973
[TBL] [Abstract][Full Text] [Related]
36. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
[TBL] [Abstract][Full Text] [Related]
37. Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.
Arturi F; Russo D; Giuffrida D; Schlumberger M; Filetti S
Eur J Endocrinol; 2000 Nov; 143(5):623-7. PubMed ID: 11078986
[TBL] [Abstract][Full Text] [Related]
38. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
Iwano S; Ito S; Kamiya S; Ito R; Kato K; Naganawa S
Nagoya J Med Sci; 2020 May; 82(2):205-215. PubMed ID: 32581401
[TBL] [Abstract][Full Text] [Related]
39. Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer.
Chudgar AV; Shah JC
Radiographics; 2017; 37(1):298-315. PubMed ID: 28076008
[TBL] [Abstract][Full Text] [Related]
40. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
